|Articles|December 1, 2003

Glaucoma implant gets FDA OK for more tests

Fort Lauderdale, FL-The FDA has given GMP Companies Inc. its approval to expand a phase III clinical trial of its Eyepass glaucoma implant.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME